Solvay SA (EBR:SOLB)
Belgium · Delayed Price · Currency is EUR 26.00
+0.52 (2.04%)
May 22, 2026, 5:37 PM CET
Solvay Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,002 | 4,123 | 4,540 | 4,880 | 5,539 | 10,105 |
Other Revenue | 643 | 623 | 590 | 1,145 | 2,440 | 1,329 |
| 4,645 | 4,746 | 5,130 | 6,025 | 7,979 | 11,434 | |
Revenue Growth (YoY) | -8.47% | -7.49% | -14.85% | -24.49% | -30.22% | 17.71% |
Cost of Revenue | 3,628 | 3,743 | 3,984 | 4,642 | 6,554 | 8,508 |
Gross Profit | 1,017 | 1,003 | 1,146 | 1,383 | 1,425 | 2,926 |
Selling, General & Admin | 535 | 509 | 419 | 526 | 565 | 1,233 |
Research & Development | 27 | 23 | 34 | 47 | 46 | 325 |
Other Operating Expenses | 49 | 36 | 97 | -10 | -310 | 157 |
Operating Expenses | 611 | 568 | 550 | 563 | 301 | 1,715 |
Operating Income | 406 | 435 | 596 | 820 | 1,124 | 1,211 |
Interest Expense | -98 | -98 | -107 | -65 | -43 | -99 |
Interest & Investment Income | 9 | 10 | 17 | 36 | 16 | 9 |
Earnings From Equity Investments | 38 | 39 | 38 | 53 | 153 | 158 |
Currency Exchange Gain (Loss) | -2 | -2 | -3 | 3 | 24 | - |
Other Non Operating Income (Expenses) | -8 | -2 | 2 | -74 | 23 | -5 |
EBT Excluding Unusual Items | 345 | 382 | 543 | 773 | 1,297 | 1,274 |
Merger & Restructuring Charges | -80 | -77 | -89 | -455 | -96 | -228 |
Impairment of Goodwill | -29 | -29 | - | -38 | - | - |
Gain (Loss) on Sale of Investments | -8 | -1 | -22 | 4 | - | 9 |
Gain (Loss) on Sale of Assets | 16 | 16 | 6 | 3 | 3 | 12 |
Asset Writedown | -58 | -58 | -45 | -57 | 37 | - |
Legal Settlements | 9 | 2 | -1 | -12 | - | 61 |
Other Unusual Items | -111 | -78 | -72 | -38 | -110 | -34 |
Pretax Income | 84 | 157 | 320 | 180 | 1,131 | 1,094 |
Income Tax Expense | 103 | 120 | 87 | 208 | 228 | 110 |
Earnings From Continuing Operations | -19 | 37 | 233 | -28 | 903 | 984 |
Earnings From Discontinued Operations | - | - | - | 2,130 | 1,016 | 5 |
Net Income to Company | -19 | 37 | 233 | 2,102 | 1,919 | 989 |
Minority Interest in Earnings | -6 | -7 | -10 | -9 | -14 | -41 |
Net Income | -25 | 30 | 223 | 2,093 | 1,905 | 948 |
Net Income to Common | -25 | 30 | 223 | 2,093 | 1,905 | 948 |
Net Income Growth | - | -86.55% | -89.34% | 9.87% | 100.95% | - |
Shares Outstanding (Basic) | 104 | 104 | 105 | 104 | 104 | 104 |
Shares Outstanding (Diluted) | 104 | 105 | 106 | 104 | 104 | 104 |
Shares Change (YoY) | -1.34% | -0.53% | 1.82% | 0.02% | 0.34% | 0.63% |
EPS (Basic) | -0.24 | 0.29 | 2.12 | 20.09 | 18.36 | 9.16 |
EPS (Diluted) | -0.25 | 0.28 | 2.10 | 20.09 | 18.30 | 9.14 |
EPS Growth | - | -86.67% | -89.55% | 9.80% | 100.26% | - |
Free Cash Flow | 482 | 491 | 343 | 944 | 1,191 | 938 |
Free Cash Flow Per Share | 4.61 | 4.65 | 3.23 | 9.06 | 11.44 | 9.04 |
Dividend Per Share | 2.430 | 2.430 | 2.430 | 2.430 | 4.050 | 3.850 |
Dividend Growth | - | - | - | -40.00% | 5.20% | 2.67% |
Gross Margin | 21.89% | 21.13% | 22.34% | 22.95% | 17.86% | 25.59% |
Operating Margin | 8.74% | 9.17% | 11.62% | 13.61% | 14.09% | 10.59% |
Profit Margin | -0.54% | 0.63% | 4.35% | 34.74% | 23.88% | 8.29% |
Free Cash Flow Margin | 10.38% | 10.35% | 6.69% | 15.67% | 14.93% | 8.20% |
EBITDA | 638 | 673 | 843 | 1,550 | 1,898 | 1,946 |
EBITDA Margin | 13.73% | 14.18% | 16.43% | 25.73% | 23.79% | 17.02% |
D&A For EBITDA | 232 | 238 | 247 | 730 | 774 | 735 |
EBIT | 406 | 435 | 596 | 820 | 1,124 | 1,211 |
EBIT Margin | 8.74% | 9.17% | 11.62% | 13.61% | 14.09% | 10.59% |
Effective Tax Rate | 122.62% | 76.43% | 27.19% | 115.56% | 20.16% | 10.05% |
Revenue as Reported | 4,645 | 4,746 | 5,130 | 6,024 | 7,979 | 11,434 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.